1. Home
  2. ALTR vs LEGN Comparison

ALTR vs LEGN Comparison

Compare ALTR & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTR
  • LEGN
  • Stock Information
  • Founded
  • ALTR 1985
  • LEGN 2014
  • Country
  • ALTR United States
  • LEGN United States
  • Employees
  • ALTR N/A
  • LEGN N/A
  • Industry
  • ALTR Computer Software: Prepackaged Software
  • LEGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALTR Technology
  • LEGN Health Care
  • Exchange
  • ALTR Nasdaq
  • LEGN Nasdaq
  • Market Cap
  • ALTR 9.3B
  • LEGN 7.8B
  • IPO Year
  • ALTR 2017
  • LEGN 2020
  • Fundamental
  • Price
  • ALTR $109.00
  • LEGN $34.08
  • Analyst Decision
  • ALTR Hold
  • LEGN Strong Buy
  • Analyst Count
  • ALTR 8
  • LEGN 13
  • Target Price
  • ALTR $100.71
  • LEGN $81.54
  • AVG Volume (30 Days)
  • ALTR 820.9K
  • LEGN 1.5M
  • Earning Date
  • ALTR 02-20-2025
  • LEGN 11-12-2024
  • Dividend Yield
  • ALTR N/A
  • LEGN N/A
  • EPS Growth
  • ALTR N/A
  • LEGN N/A
  • EPS
  • ALTR 0.38
  • LEGN N/A
  • Revenue
  • ALTR $644,660,000.00
  • LEGN $520,183,000.00
  • Revenue This Year
  • ALTR $9.00
  • LEGN $120.77
  • Revenue Next Year
  • ALTR $8.81
  • LEGN $68.54
  • P/E Ratio
  • ALTR $284.08
  • LEGN N/A
  • Revenue Growth
  • ALTR 7.15
  • LEGN 122.96
  • 52 Week Low
  • ALTR $75.71
  • LEGN $32.50
  • 52 Week High
  • ALTR $113.12
  • LEGN $70.13
  • Technical
  • Relative Strength Index (RSI)
  • ALTR 68.66
  • LEGN 31.74
  • Support Level
  • ALTR $105.50
  • LEGN $32.50
  • Resistance Level
  • ALTR $106.96
  • LEGN $35.08
  • Average True Range (ATR)
  • ALTR 0.88
  • LEGN 1.98
  • MACD
  • ALTR 0.04
  • LEGN -0.51
  • Stochastic Oscillator
  • ALTR 95.04
  • LEGN 13.10

About ALTR Altair Engineering Inc.

Altair Engineering Inc is a provider of enterprise-class engineering software enabling origination of the entire product lifecycle from concept design to in-service operation. The integrated suite of software provided by the company optimizes design performance across multiple disciplines encompassing structures, motion, fluids, thermal management, system modeling, and embedded systems. It operates through two segments: Software which includes the portfolio of software products such as solvers and optimization technology products, modeling and visualization tools, industrial and concept design tools, and others; and Client Engineering Services which provides client engineering services to support customers. Majority of its revenue comes from the software segment.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: